Drugs of the Future Table of Contents: 2009, vol. 34, No. 5


MONOGRAPHS

Diazepinomicin. Apoptosis inducer, Oncolytic.
Campas, C.
349
Full: PDF (45 K)
Golimumab. Human anti-TNF-α monoclonal antibody, Treatment of inflammation.
Dulsat, C., Mealy, N.
352
Full: PDF (68 K)
JX-594. Recombinant vaccinia virus expressing GMCSF, Oncolytic.
Kim, S.G., Hwang, T.H.
358
Full: PDF (116 K)
Voreloxin. DNA-intercalating drug, Topoisomerase II inhibitor, Oncolytic.
Moualla, H., Mills, D.A., Hromas, R., Verschraegen, C.F., Castaner, R., Bolos, J.
363
Full: PDF (126 K)

REVIEW ARTICLES

Anti-CS1 antibodies: a new therapeutic approach to treat multiple myeloma.
Hsi, E.D., Afar, D.
375
Full: PDF (206 K)
Pharmacological treatments for tinnitus: new and old.
Salvi, R., Lobarinas, E., Sun, W.
381
Full: PDF (174 K)

FILLING THE GAPS IN DRUG THERAPY

Kawasaki's disease.
Dulsat, C., Mealy, N.
401
Full: PDF (58 K)

TARGETS TO WATCH

Therapeutic targets for multiple sclerosis.
Sorbera, L.A., Dulsat, C., Rosa, E.
405
Full: PDF (193 K)

MEETING REPORT

The 9th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) 2009.
The latest news from two disease fronts.

P. Cole
419
Full: PDF (115 K)